Journal of Medicinal Chemistry · 2022 · 17 citations · 38 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryNeuropharmacologyDopaminergic PharmacologyDopaminergic SignalingGlioblastomaLead Compound DesignLigand BindingReceptor PharmacologyBrain Targeting LigandsCell Viability AssaysDopamine Receptor SubtypesDopaminergic Drug DiscoveryGlioblastoma Drug TherapyGlioblastoma Molecular SubtypesGlioblastoma Targeted TherapyLead Compound Discovery
induced an increased effect in reducing the cell viability with respect to temozolomide, which is the first-choice chemotherapeutic drug in GBM.
38
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Lucia Ricci‐Vitiani, Roberto Pallini, Mauro Biffoni et al. · Nature · 2010 · 1.4K citations
Medicine, Cancer Biology, Oncology +14
Multiple dopamine D4 receptor variants in the human population
Hubert H.M. Van Tol, Caren M. Wu, Hong‐Chang Guan et al. · Nature · 1992 · 967 citations